| abstract |
The present invention relates to compounds according to the general formula (I), with the definitions of the substituents X, R1 and R2 given below in the text, as well as their physiologically acceptable salts, methods for producing these compounds and their use as pharmaceuticals. , These compounds are kinase inhibitors, in particular inhibitors of the kinase GSK-3 β (glycogen synthase kinase-3 β). |